Malignant lymphoma (ML) represents a diverse group of diseases that arise from clonal proliferation of lymphocytes. The number of new ML cases in Japan was approximately 20 per 100,000, and it has been increasing every year. 1,2 ML is classified histologically into Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). NHL arising from the neoplastic proliferation of germinal center B-cells and exhibiting a follicular architectural pattern, at least partially, is defined as follicular lymphoma (FL). FL is the second-most common subtype of low-grade B-cell lymphoma. 3,4 Sites most frequently affected with FL are lymph nodes (LNs), and most patients have lymphadenopathy as their first subjective symptom. 5 However, cases with FL at extranodal sites, including the gastrointestinal tract, especially small intestine, skin, thyroid gland, salivary gland, lungs, nasopharynx, larynx, breast, and brain, were reported. 6-10 Occasionally, FL occurs in the oral cavity; 10 however, clinical characteristics, such as frequent onset or affected sites, treatment efficacy, and patient prognosis are unclear owing to the limited studies done. Here, we describe a rare case of solitary primary FL of the buccal mucosa with good prognosis achieved by treatment with chemotherapy and radiotherapy. We further summarize the features of primary oral follicular lymphoma (OFL) from literature, highlighting the importance of accurate diagnosis and treatment at an early stage to improve prognosis.